和胃愈疡方结合奥美拉唑治疗脾虚郁热型胃ESD后溃疡的临床研究

林冠凯; 李保良; 叶小峰; 张琪

和胃愈疡方结合奥美拉唑治疗脾虚郁热型胃ESD后溃疡的临床研究

南京中医药大学附属常州市中医医院，江苏常州 213003

计量
- 文章访问数: 544
- HTML全文浏览量: 16
- PDF下载量: 413
- 被引次数: 0
出版历程
- 刊出日期: 2020-07-10

Clinical Study on the Efficacy of Hewei Yuyang Formula Combined with Omeprazole on the Postoperative Ulcer Induced by Gastric Endoscopic Submucosal Dissection for Patients with Spleen Deficiency and Heat Constraint

摘要

摘要: 目的观察和胃愈疡方结合奥美拉唑治疗脾虚郁热型胃内镜黏膜下剥离术（ESD）后溃疡的临床疗效和安全性。方法将60例脾虚郁热型胃ESD后溃疡患者随机分为对照组和治疗组，对照组予以奥美拉唑治疗，治疗组给予和胃愈疡方结合奥美拉唑治疗，2组疗程均为4周。疗程结束后比较2组的溃疡面积缩小率、溃疡再生黏膜组织学成熟度、血清前列腺素E₂（PGE₂）水平以及中医证候积分。结果治疗后2组溃疡面积均较治疗前缩小（P<0.05），治疗组溃疡缩小率大于对照组（P<0.05），治疗组溃疡再生黏膜组织学成熟度优于对照组（P<0.05）；2组患者治疗后血清PGE₂水平较治疗前升高，证候积分较治疗前下降（P<0.05），治疗组均较对照组显著（P<0.05）。结论和胃愈疡方结合奥美拉唑治疗脾虚郁热型胃ESD后溃疡疗效确切，能加快溃疡愈合速度，提高溃疡愈合质量，显著缓解临床症状，同时具有较高的安全性。
- 胃溃疡 /
- 内镜黏膜下剥离术 /
- 和胃愈疡方 /
- 脾虚郁热 /
- 奥美拉唑
Abstract: OBJECTIVE To observe the clinical efficacy and safety of the Hewei Yuyang formula combined with Omeprazole on the postoperative ulcers induced by gastric endoscopic submucosal dissection (ESD) for patients with spleen deficiency and heat constraint. METHODS Sixty post-operative ulcer patients with spleen deficiency and heat constraint type induced by gastric ESD were randomly divided into the control group and the treatment group with 30 cases in each group. The control group was given Omeprazole while the treatment group was given Omeprazole and Hewei Yuyang formula for four weeks. After treatment， the ulcer area reduction rates， the ulcer regenerated mucosal histological maturity， serum prostaglandin E₂ (PGE₂) levels， and traditional Chinese medicine (TCM) syndrome scores were compared. RESULTS After treatment， the ulcer area reduction rates in the two groups were decreased (P<0.05)， and the reduction rate in the treatment group decreased more significantly (P<0.05). The ulcer regenerated mucosal histological maturity in the treatment group was better than that of the control group (P<0.05). Serum PGE₂ levels in two groups were higher than those before treatment while the TCM syndrome scores were lower than those before treatment (P<0.05)， and the treatment group showed more significant differences (P<0.05). CONCLUSION Hewei Yuyang formula combined with Omeprazole has exact efficacy on the postoperative ulcer induced by gastric ESD for patients with spleen deficiency and heat constraint. The combined therapy can significantly speed up the healing of ulcers， improve the quality of healing， and relieve clinical symptoms with higher safety.
- gastric ulcer /
- endoscopic submucosal dissection /
- Hewei Yuyang formula /
- spleen deficiency and heat constraint /
- Omeprazole

HTML全文

参考文献(17)

[1]	杜奕奇，蔡全才，廖专，等.中国早期胃癌筛查流程专家共识意见(草案)(2017年，上海)[J].胃肠病学，2018，23(2):92-97.
[2]	盛剑秋，金鹏．早期胃癌内镜诊断进展[J]．中华消化杂志，2018，38(3)：149-151．
[3]	LEE IS，YOOK JH，PARK YS，et al．Suitability of endoscopic submucosal dissection for treatment of submucosal gastric cancers[J]．Br J Surg，2013，100(5)：668-673．
[4]	SHIMOZATO A， SASAKI M， OGASAWARA N， et al. Risk factors for delayed ulcer healing after endoscopic submucosal dissection of gastric neoplasms[J]. J Gastrointest Liver Dis， 2017， 26(4)：363-368.
[5]	YAMAMOTO Y，KIKUCHI D，NAGAMI Y，et al．Management of adverse events related to endoscopic resection of upper gastrointestinal neoplasms：Review of the literature and recommendations from experts[J]．Dig Endosc，2019，31(S1)：4-20．
[6]	KANG H， KIM BJ， CHOI G， et al. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis[J]. Medicine， 2019，98(24)：e15860.
[7]	中国中西医结合学会消化系统疾病专业委员会．消化性溃疡中西医结合诊疗共识意见(2011年天津)[J]．中国中西医结合杂志，2012，32(6)：733-737．
[8]	LEE SH， LEE CK， CHUNG IK， et al. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: A retrospective analysis and prospective validation study[J].Digest Dis Sci， 2011，57（2）：429-434.
[9]	PANS，LIAO CH，LIEN GS，et al．Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine[J]．Gastroenterology，1991，101(5)：1187-1191．
[10]	中药新药临床研究指导原则(试行)[M]．北京：中国医药科技出版社，2002：151-155．
[11]	朱良春．章次公医案[M]．南京：江苏科学技术出版社，1980：136-137．
[12]	林冠凯，李保良，张琪．和胃愈疡颗粒结合四联疗法治疗寒热错杂型幽门螺杆菌相关性消化性溃疡的临床研究[J]．中药材，2017，40(6)：1465-1467．
[13]	卜雕雕，苏卓，张丹，等．基于网络药理学左金丸治疗胃溃疡的机制[J]．中成药，2019，41(6)：1264-1271．
[14]	张年，李兆星，李娟，等．茯苓的化学成分与生物活性研究进展[J]．世界科学技术：中医药现代化，2019，21(2)：220-233．
[15]	杨士豹，江征．微粉化乌贝分散片工艺研究及药效验证[J]．时珍国医国药，2007，18(12)：3066-3068．
[16]	饶文龙，张浩，张熹玮，等．白及药理作用研究进展[J]．上海中医药杂志，2015，49(8)：91-93．
[17]	FABRE JE，NGUYEN M，ATHIRAKUL K，et al．Activation of the murine EP₃ receptor for PGE₂ inhibits cAMP production and promotes platelet aggregation[J]．J Clin Invest，2001，107(5)：603-610．